Your browser doesn't support javascript.
loading
Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan.
Aoki, Masahiko; Kadowaki, Shigenori; Takahashi, Naoki; Suzuki, Takeshi; Oshima, Kotoe; Ando, Takayuki; Yamamoto, Yoshiyuki; Kawakami, Kentaro; Kito, Yosuke; Matsumoto, Toshihiko; Shimozaki, Keitaro; Miyazaki, Yasuhiro; Yamaguchi, Toshifumi; Nagase, Michitaka; Tamura, Takao; Amanuma, Yusuke; Esaki, Taito; Miura, Yuji; Akiyoshi, Kohei; Baba, Eishi; Makiyama, Akitaka; Negoro, Yuji; Nakashima, Koji; Sugimoto, Naotoshi; Nagashima, Kengo; Shoji, Hirokazu; Boku, Narikazu.
Afiliación
  • Aoki M; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Kadowaki S; Department of Early Clinical Development, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Takahashi N; Department of Clinical Oncology, Aichi Cancer Center Hospital, Aichi, Japan.
  • Suzuki T; Division of Gastroenterology, Saitama Cancer Center, Saitama, Japan.
  • Oshima K; Department of Gastroenterology, The Cancer Institute Hospital, Tokyo, Japan.
  • Ando T; Department of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Yamamoto Y; Third Department of Internal Medicine, University of Toyama, Toyama, Japan.
  • Kawakami K; Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
  • Kito Y; Department of Medical Oncology, Keiyukai Sapporo Hospital, Hokkaido, Japan.
  • Matsumoto T; Department of Medical Oncology, Ishikawa Prefectural Central Hospital, Ishikawa, Japan.
  • Shimozaki K; Department of Internalmedicine, Himeji Red Cross Hospital, Hyogo, Japan.
  • Miyazaki Y; Cancer Treatment Center, Kansai Medical University Hospital, Osaka, Japan.
  • Yamaguchi T; Division of Gastroenterology and Hepatology, Depart of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Nagase M; Department of Surgery, Osaka General Medical Center, Osaka, Japan.
  • Tamura T; Cancer Chemotherapy Center, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Amanuma Y; Department of Medical Oncology, Saku Central Hospital Advanced Care Center, Nagano, Japan.
  • Esaki T; Department of Medical Oncology, Kindai University Nara Hospital, Nara, Japan.
  • Miura Y; Clinical Trial Promotion Department, Chiba Cancer Center, Chiba, Japan.
  • Akiyoshi K; Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Baba E; Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan.
  • Makiyama A; Department of Medical Oncology, Osaka City General Hospital, Osaka, Japan.
  • Negoro Y; Department of Oncology and Social Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
  • Nakashima K; Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan.
  • Sugimoto N; Cancer Center, Gifu University Hospital, Gifu, Japan.
  • Nagashima K; Division of Gastroenterological Medicine, Kochi Health Sciences Center, Kochi, Japan.
  • Shoji H; Department of Clinical Oncology, University of Miyazaki Hospital, Miyazaki, Japan.
  • Boku N; Department of Genetic Oncology, Osaka International Cancer Institute, Osaka, Japan.
Gastric Cancer ; 26(1): 132-144, 2023 01.
Article en En | MEDLINE | ID: mdl-36316527
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Nivolumab Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Gastric Cancer Asunto de la revista: GASTROENTEROLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Nivolumab Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Gastric Cancer Asunto de la revista: GASTROENTEROLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Japón